Neumarker.ai turns raw EEG into objective biomarkers that improve diagnosis and treatment for depression, schizophrenia, epilepsy — and now autism, including data driven subtyping and intervention assistance. We partner with major hospitals and are backed by top healthcare investors—and we're growing our R&D team.
What you'll do
What we're looking for
Why join us
Neumarker.ai is an equal opportunity employer.